| Stephen Lawless, MD | |
|
1701 Augustine Cut Off, Wilmington, DE 19803-4415 | |
| (302) 652-3016 | |
| (302) 571-6270 |
| Full Name | Stephen Lawless |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 43 Years |
| Location | 1701 Augustine Cut Off, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922090026 | NPI | - | NPPES |
| 0000018001 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | C10002534 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delaware Radiology Associates Pa | 1557620036 | 36 |
| Abby Medical Llc | 8628146396 | 12 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
| Entity Name | Koniver Fiss Mansoory |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083615561 PECOS PAC ID: 3971591843 Enrollment ID: O20040501000171 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
| Entity Name | Abby Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750554572 PECOS PAC ID: 8628146396 Enrollment ID: O20081008000086 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
| Entity Name | Delaware Radiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740706175 PECOS PAC ID: 1557620036 Enrollment ID: O20180108001828 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
| Entity Name | Lenox Hill Radiology & Medical Imaging Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821036807 PECOS PAC ID: 2264424712 Enrollment ID: O20190612000432 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
| Entity Name | Hudson Valley Radiology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174574115 PECOS PAC ID: 4486567690 Enrollment ID: O20190909002521 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Lawless, MD 1701 Augustine Cut Off, Wilmington, DE 19803-4415 Ph: (302) 652-3016 | Stephen Lawless, MD 1701 Augustine Cut Off, Wilmington, DE 19803-4415 Ph: (302) 652-3016 |
News Archive
In a special report on water the Economist examines the causes of and growing concerns over increasing scarcity around the world.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.
Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.
› Verified 8 days ago
Dr. Lauren Ashley May, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 | |
Dr. Vinay Vardhan Reddy Kandula, MBBS,FRCR, MRCP, DCH Radiology Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Department Of Radiology, A.i Dupont Children's Hospital, Wilmington, DE 19803 Phone: 302-651-4664 Fax: 302-651-4476 | |
William Rumancik, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1732a Marsh Rd # 175, Wilmington, DE 19810 Phone: 302-842-8234 | |
Michael Leviton, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1701 Augustine Cut Off, Wilmington, DE 19803 Phone: 302-652-3016 Fax: 302-571-6270 | |
Dr. Steven H Klein, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Dr. H Theodore Harcke, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Kerry A Bron, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 |